Librax (5 mg chlordiazepoxide HCl and 2.5 mg clidinium bromide) capsules, 100-count bottle, Rx Only, Manufactured in Canada by: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7 Canada; Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, NDC 0187-4100-10.
Published June 22, 2016 · Recall initiated: April 18, 2015
Summary
FDA records drug Class III recall D-1034-2016, published June 22, 2016 and initiated April 18, 2015. Recalling firm: Valeant Pharmaceuticals North America LLC; Status: Terminated; Reported quantity: 6,321 bottles; Lot: Lot #: 14L024P, Exp 06/16; and 15E029P, Exp 04/19. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if LIBRAX has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LIBRAX
- Manufacturer
- Valeant Pharmaceuticals North America LLC
- Distributor
- Nationwide and Puerto Rico
- UPC
- 0301874100101
- Lot
- Lot #: 14L024P, Exp 06/16; and 15E029P, Exp 04/19
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVancomycin Hydrochloride for Injection, USP, 10 g, 100 mL vial, Rx only, Hospira, Lake Forest, IL, NDCJune 22, 2016
- FDAChlordiazepoxide HCl/Clidinium Bromide capsules, 5 /2.5 mg, 100-count bottle, Rx Only, Manufactured in CanadaJune 22, 2016
- FDALodrane D (Brompheniramine maleate 4 mg and Pseudoephedrine HCl 60 mg) Capsules, 60-count bottles, DistributedJune 22, 2016
- FDALisinopril Tablets USP, 30 mg, 100-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540,June 22, 2016
- FDADoxycycline, USP Capsules 40 mg, Packaged in 30 ct Bottles, Rx Only. Marketed by: Prasco Laboratories, Mason,June 22, 2016
- FDAPramipexole Dihydrochloride Extended Release Tablets, 0.375 mg, Rx Only, 30 count bottles, Manufactured By:June 22, 2016
Questions about this recall
Was Librax (5 mg chlordiazepoxide HCl and 2.5 mg clidinium bromide) capsules, 100-count bottle, Rx Only, Manufactured in Canada by: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7 Canada; Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, NDC 0187-4100-10. recalled?
Yes. FDA published recall D-1034-2016 on June 22, 2016. Reported hazard: Failed Impurities/Degradation Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LIBRAX. UPC: 0301874100101.